$SPFX
STANDARD PREMIUM FINANCE HOLDINGS, INC. Stock $spfx

$spfx Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000107997324000379 Filed on March 15, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$2.830M	$2.741M	$9.723M
YoY Change	36.13%	29.69%	19.21%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.291M	$1.219M	$4.304M
YoY Change	31.92%	41.69%	12.55%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$7.967K	$6.150K	$25.29K
YoY Change	27.33%	-0.49%	13.5%
% of Gross Profit
Operating Expenses	$1.582M	$1.438M	$5.212M
YoY Change	31.04%	32.03%	8.22%
Operating Profit
YoY Change
Interest Expense	$1.083M	-$1.073M	$3.798M
YoY Change	36.82%	38.5%	63.15%
% of Operating Profit
Other Income/Expense, Net	$47.76K		$124.5K
YoY Change	73.83%		-31.52%
Pretax Income	$164.6K	$230.0K	$712.9K
YoY Change	106.39%	-7.86%	-29.58%
Income Tax	$45.79K	$59.42K	$180.5K
% Of Pretax Income	27.82%	25.84%	25.32%
Net Earnings	$118.8K	$141.5K	$532.4K
YoY Change	72.48%	-33.24%	-33.96%
Net Earnings / Revenue	4.2%	5.16%	5.48%
Basic Earnings Per Share	$0.03		$0.14
Diluted Earnings Per Share	$0.03	$0.04	$0.13
COMMON SHARES
Basic Shares Outstanding	2.905M shares	2.905M shares	2.905M shares
Diluted Shares Outstanding	3.052M shares		3.295M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.140K	$45.24K	$45.24K
YoY Change	-99.56%	-89.26%	-89.26%
Cash & Equivalents	$1.144K	$45.24K
Short-Term Investments
Other Short-Term Assets	$722.5K	$307.2K	$307.2K
YoY Change	106.55%	-11.92%	-11.92%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$65.95M	$61.09M	$61.09M
YoY Change	25.32%	21.59%	21.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$141.2K	$122.5K	$242.0K
YoY Change	45.07%	18.25%	-31.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.070M	$1.041M	$1.041M
YoY Change	16.92%	16.73%	16.73%
Total Long-Term Assets	$1.533M	$1.283M	$1.283M
YoY Change	24.69%	3.16%	3.16%
TOTAL ASSETS
Total Short-Term Assets	$65.95M	$61.09M	$61.09M
Total Long-Term Assets	$1.533M	$1.283M	$1.283M
Total Assets	$67.49M	$62.38M	$62.38M
YoY Change	25.3%	21.14%	21.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$1.914M	$1.606M	$1.606M
YoY Change	22.34%	11.48%	11.48%
Deferred Revenue
YoY Change
Short-Term Debt	$48.93M	$45.22M	$45.22M
YoY Change	32.26%	30.93%	30.93%
Long-Term Debt Due	$3.416M	$2.597M	$2.597M
YoY Change	266.28%	67.15%	67.15%
Total Short-Term Liabilities	$54.26M	$49.43M	$49.43M
YoY Change	37.39%	31.68%	31.68%
LONG-TERM LIABILITIES
Long-Term Debt	$6.566M	$6.521M	$6.521M
YoY Change	-20.97%	-17.74%	-17.74%
Other Long-Term Liabilities	$168.2K	$30.25K	$30.25K
YoY Change	190.45%	-59.04%	-59.04%
Total Long-Term Liabilities	$6.734M	$6.551M	$6.551M
YoY Change	-19.51%	-18.12%	-18.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$54.26M	$49.43M	$49.43M
Total Long-Term Liabilities	$6.734M	$6.551M	$6.551M
Total Liabilities	$60.99M	$55.98M	$55.98M
YoY Change	27.44%	22.93%	22.93%
SHAREHOLDERS EQUITY
Retained Earnings	$3.072M	$2.982M
YoY Change	17.89%	16.22%
Common Stock	$2.905K	$2.905K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.494M	$6.397M	$6.397M
YoY Change
Total Liabilities & Shareholders Equity	$67.49M	$62.38M	$62.38M
YoY Change	25.3%	21.14%	21.14%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$118.8K	$141.5K	$532.4K
YoY Change	72.48%	-33.24%	-33.96%
Depreciation, Depletion And Amortization	$7.967K	$6.150K	$25.29K
YoY Change	27.33%	-0.49%	13.5%
Cash From Operating Activities	$1.502M	$197.5K	$2.684M
YoY Change	60.63%	-517.29%	65.21%
INVESTING ACTIVITIES
Capital Expenditures	$26.67K	$53.60K	$62.72K
YoY Change		123.8%	28.66%
Acquisitions
YoY Change
Other Investing Activities	-$4.723M	-$1.292M	-$12.24M
YoY Change	72.22%	-141.71%	242.56%
Cash From Investing Activities	-$4.750M	-$1.346M	-$12.31M
YoY Change	73.19%	-143.78%	239.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.204M	1.193M	$9.246M
YoY Change	94.55%	-144.17%	285.51%
NET CHANGE
Cash From Operating Activities	$1.502M	197.5K	$2.684M
Cash From Investing Activities	-$4.750M	-1.346M	-$12.31M
Cash From Financing Activities	$3.204M	1.193M	$9.246M
Net Change In Cash	-$44.10K	45.25K	-$376.0K
YoY Change	-72.56%	-86.05%	-193.94%
FREE CASH FLOW
Cash From Operating Activities	$1.502M	$197.5K	$2.684M
Capital Expenditures	$26.67K	$53.60K	$62.72K
Free Cash Flow	$1.475M	$143.9K	$2.622M
YoY Change	57.78%	-301.85%	66.34%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103591	usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001807893
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-56243
CY2023	dei	Entity Registrant Name EntityRegistrantName	Standard Premium Finance Holdings, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-2624094
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	13590 SW 134th Avenue
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 214
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33186
CY2023	dei	City Area Code CityAreaCode	305
CY2023	dei	Local Phone Number LocalPhoneNumber	232-2752
CY2023	dei	Security12g Title Security12gTitle	Common Stock, $.001 par value per share
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	7315839	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2905016	shares
CY2023	dei	Auditor Firm AuditorFirmId	5036
CY2023	dei	Auditor Name AuditorName	Assurance Dimensions
CY2023	dei	Auditor Location AuditorLocation	Margate, Florida
CY2023Q4	us-gaap	Cash Cash	45239	usd
CY2022Q4	us-gaap	Cash Cash	421211	usd
CY2023Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	1501593	usd
CY2022Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	1129498	usd
CY2023Q4	spfx	Premium Finance Contracts And Related Receivable Net PremiumFinanceContractsAndRelatedReceivableNet	60739699	usd
CY2022Q4	spfx	Premium Finance Contracts And Related Receivable Net PremiumFinanceContractsAndRelatedReceivableNet	49474903	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	307206	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	348795	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	61092144	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	50244909	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	122500	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	80840	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	196407	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	38664	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	51920	usd
CY2023Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	650237	usd
CY2022Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	603816	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	391000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	288164	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	1041237	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	891980	usd
CY2023Q4	us-gaap	Assets Assets	62375385	usd
CY2022Q4	us-gaap	Assets Assets	51488807	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	168543	usd
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts	0	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	42374715	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	32713625	usd
CY2023Q4	srt	Drafts Payable DraftsPayable	2681359	usd
CY2022Q4	srt	Drafts Payable DraftsPayable	1827884	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2181400	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1340597	usd
CY2023Q4	spfx	Note Payable Stockholders And Related Parties Current Portion NotePayableStockholdersAndRelatedPartiesCurrentPortion	310000	usd
CY2022Q4	spfx	Note Payable Stockholders And Related Parties Current Portion NotePayableStockholdersAndRelatedPartiesCurrentPortion	109000	usd
CY2023Q4	spfx	Payroll Protection Program Loan Net Of Current Portion PayrollProtectionProgramLoanNetOfCurrentPortion	92785	usd
CY2022Q4	spfx	Payroll Protection Program Loan Net Of Current Portion PayrollProtectionProgramLoanNetOfCurrentPortion	91852	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	50594	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	122554	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	13166	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	12494	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1555044	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1317699	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	49427606	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	37535705	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4684157	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	5946324	usd
CY2023Q4	spfx	Note Payable Stockholders And Related Parties Net Of Current Portion NotePayableStockholdersAndRelatedPartiesNetOfCurrentPortion	1778000	usd
CY2022Q4	spfx	Note Payable Stockholders And Related Parties Net Of Current Portion NotePayableStockholdersAndRelatedPartiesNetOfCurrentPortion	1816000	usd
CY2023Q4	spfx	Payroll Protection Program Loan Net Of Non Current Portion PayrollProtectionProgramLoanNetOfNonCurrentPortion	31139	usd
CY2022Q4	spfx	Payroll Protection Program Loan Net Of Non Current Portion PayrollProtectionProgramLoanNetOfNonCurrentPortion	123924	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30246	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	73853	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	27393	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	40559	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6550935	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8000660	usd
CY2023Q4	us-gaap	Liabilities Liabilities	55978541	usd
CY2022Q4	us-gaap	Liabilities Liabilities	45536365	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	166	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	166	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2905016	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2905016	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2905016	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2905016	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2905	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2905	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3411851	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3383651	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2981922	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2565720	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6396844	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5952442	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	62375385	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51488807	usd
CY2023	us-gaap	Revenues Revenues	9723010	usd
CY2022	us-gaap	Revenues Revenues	8156537	usd
CY2023	us-gaap	Interest Expense InterestExpense	3798046	usd
CY2022	us-gaap	Interest Expense InterestExpense	2328004	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	1767153	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	1557223	usd
CY2023	us-gaap	Leasing Commissions Expense LeasingCommissionsExpense	1150746	usd
CY2022	us-gaap	Leasing Commissions Expense LeasingCommissionsExpense	976990	usd
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	950815	usd
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	734040	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	310951	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	374144	usd
CY2023	us-gaap	Postage Expense PostageExpense	114980	usd
CY2022	us-gaap	Postage Expense PostageExpense	110752	usd
CY2023	us-gaap	Other Expenses OtherExpenses	124484	usd
CY2022	us-gaap	Other Expenses OtherExpenses	181787	usd
CY2023	us-gaap	Other General Expense OtherGeneralExpense	792942	usd
CY2022	us-gaap	Other General Expense OtherGeneralExpense	881276	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	9010117	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	7144216	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	712893	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1012321	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	180491	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	206190	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	532402	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	806131	usd
CY2023	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	116200	usd
CY2022	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	89191	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	416202	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	716940	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2905016	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2905016	shares
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3622856	usd
CY2023	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	168543	usd
CY2022	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-153264	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	9556389	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	2167052	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	350212	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	575511	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	771576	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	288400	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	190000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3294511	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3407949	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4534779	usd
CY2022	spfx	Series A Convertible Preferred Stock Issued For Cash SeriesAConvertiblePreferredStockIssuedForCash	400000	usd
CY2022	spfx	Series A Convertible Preferred Stock Issued In Exchange For Note Payable SeriesAConvertiblePreferredStockIssuedInExchangeForNotePayable	270000	usd
CY2022	spfx	Warrants Issued For Services WarrantsIssuedForServices	10800	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	19878	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	45	usd
CY2022	spfx	Dividends Paid On Preferred Stock DividendsPaidOnPreferredStock	-89191	usd
CY2022	us-gaap	Profit Loss ProfitLoss	806131	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5952442	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	28200	usd
CY2023	spfx	Dividends Paid On Preferred Stock DividendsPaidOnPreferredStock	-116200	usd
CY2023	us-gaap	Profit Loss ProfitLoss	532402	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6396844	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	532402	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	806131	usd
CY2023	us-gaap	Depreciation Depreciation	25292	usd
CY2022	us-gaap	Depreciation Depreciation	22283	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-0	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2167	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	115567	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	103585	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	13256	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	13256	usd
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	950815	usd
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	734040	usd
CY2023	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-104701	usd
CY2022	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-70198	usd
CY2023	spfx	Options Issued For Services OptionsIssuedForServices	28200	usd
CY2022	spfx	Options Issued For Services OptionsIssuedForServices	19878	usd
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	0	usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	10800	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-41589	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-189344	usd
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	102836	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-58836	usd
CY2023	spfx	Increasedecrease In Drafts Payable IncreasedecreaseInDraftsPayable	853475	usd
CY2022	spfx	Increasedecrease In Drafts Payable IncreasedecreaseInDraftsPayable	-107394	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	237345	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-194829	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-115567	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-103585	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2684239	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1624710	usd
CY2023	spfx	Disbursements Under Premium Finance Contracts Receivable Net DisbursementsUnderPremiumFinanceContractsReceivableNet	12215611	usd
CY2022	spfx	Disbursements Under Premium Finance Contracts Receivable Net DisbursementsUnderPremiumFinanceContractsReceivableNet	3534670	usd
CY2023	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	46421	usd
CY2022	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	43939	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	18517	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4500	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	62718	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48747	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12306233	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	35000	usd
CY2023	spfx	Repayment Of Notes Payable Stockholders And Related Parties RepaymentOfNotesPayableStockholdersAndRelatedParties	27000	usd
CY2022	spfx	Repayment Of Notes Payable Stockholders And Related Parties RepaymentOfNotesPayableStockholdersAndRelatedParties	181302	usd
CY2023	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	12494	usd
CY2022	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	11857	usd
CY2023	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	400000	usd
CY2023	spfx	Repayment Of Ppp Loan RepaymentOfPppLoan	91852	usd
CY2022	spfx	Repayment Of Ppp Loan RepaymentOfPppLoan	55224	usd
CY2023	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	usd
CY2022	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	45	usd
CY2023	spfx	Dividend Distributions Paid DividendDistributionsPaid	116200	usd
CY2022	spfx	Dividend Distributions Paid DividendDistributionsPaid	89191	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9246022	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2398370	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-375972	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	400224	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	421211	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20987	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45239	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	421211	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	78046	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	395240	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	3704469	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2201574	usd
CY2023	spfx	Debt Exchanged For Series Convertible Preferred Stock DebtExchangedForSeriesConvertiblePreferredStock	0	usd
CY2022	spfx	Debt Exchanged For Series Convertible Preferred Stock DebtExchangedForSeriesConvertiblePreferredStock	270000	usd
CY2023	spfx	Operating Lease Asset Obtained In Exchange For Operating Lease Liability OperatingLeaseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022	spfx	Operating Lease Asset Obtained In Exchange For Operating Lease Liability OperatingLeaseAssetObtainedInExchangeForOperatingLeaseLiability	71038	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zzhK5wHjubf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_863_zZEIMyQKKVa6"><b>Use of Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions used in valuation of deferred tax assets, allowance for credit losses, depreciable lives of property and equipment, and valuation of stock-based compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	250200	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	482479	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	168543	usd
CY2023Q4	us-gaap	Unearned Premiums UnearnedPremiums	87618261	usd
CY2022Q4	us-gaap	Unearned Premiums UnearnedPremiums	71315354	usd
CY2023	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.170	pure
CY2022	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.153	pure
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zVyLOkmTXyNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_zne6NYjsNpm9"><b>Concentration of Credit and Financial Instrument Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash and accounts receivable from customers, agents, and insurance companies. The Company maintains its cash balances at two banks. Accounts at this financial institution are insured by the Federal Deposit Insurance Corporation up to $<span id="xdx_904_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20231231_zClom7eFlkq3" title="FDIC insured amount">250,000</span>. Uninsured balances are approximately $<span id="xdx_908_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20231231_zgVcV2R5rd9d" title="Uninsured balances">250,200</span> and $<span id="xdx_908_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20221231_zbztgJW4fYC7" title="Uninsured balances">482,479 </span>at December 31, 2023 and 2022, respectively. The Company mitigates this risk by maintaining its cash balances at a high-quality financial institution. The following table provides a reconciliation between uninsured balances and cash per the consolidated balance sheet:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--SchedulesOfReconciliationBetweenUninsuredBalancesAndCashTextBlock_zpt9IJgtqEOi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B8_z0lw30ekuoG8" style="display: none">Schedule of reconciliation between uninsured balances and cash per the consolidated balance sheet</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20231231_zGAA2B6kpxc2" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_zRp4Ned5K612" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>December 31, 2023</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>December 31, 2022</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td></tr> <tr id="xdx_400_eus-gaap--CashUninsuredAmount_iI_pp0p0_maCAOAzrMU_zjUaMMYbPHHc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: justify">Uninsured Balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">250,200</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">482,479</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--InsuredBalances_iI_pp0p0_maCAOAzrMU_zAhTjoya6Msa" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Plus: Insured balances</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--BalancesAtInstitutionsThatDoNotExceedFdicLimit_iI_pp0p0_maCAOAzrMU_zkSjmV67YLWe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Plus: Balances at other institutions that do not exceed FDIC limit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,239</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,758</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--PlusCashOverdraft_iI_pp0p0_d0_maCAOAzrMU_zzcv3vbG01Kg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Plus: Cash overdraft</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">168,543</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--OutstandingChecks_iI_pp0p0_maCAOAzrMU_zcOil900vofb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Less: Outstanding checks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(668,743</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(329,026</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 11pt; text-align: justify; padding-bottom: 1pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--CashAndOverdraftAmount_iTI_pp0p0_mtCAOAzrMU_zuQpi8RBY7Jf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Cash per Consolidated Balance Sheet</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">45,239</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">421,211</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A5_z9VUXExlrIk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company controls its credit risk in accounts receivable through credit standards, limits on exposure, by monitoring the financial condition of insurance companies, by adhering to statutory cancellation policies, and by monitoring and pursuing collections from past due accounts. We cancel policies at the earliest permissible date allowed by the statutory cancellation regulations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Approximately <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__srt--StatementGeographicalAxis__stpr--FL__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z587iy7JgGga" title="Concentration risk percentage">61</span>% and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--StatementGeographicalAxis__stpr--FL__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zD9jcowfEyI2" title="Concentration risk percentage">59</span>% of the Company’s business activity is with customers located in Florida for 2023 and 2022, respectively. Approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__srt--StatementGeographicalAxis__stpr--GA__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zqY18aPbaUyb" title="Concentration risk percentage">10</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--StatementGeographicalAxis__stpr--GA__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zH5j7CcMwBGj" title="Concentration risk percentage">12</span>% of the Company’s business activity is with customers located in Georgia for 2023 and 2022, respectively. Approximately <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__srt--StatementGeographicalAxis__stpr--NC__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zmKInxRaelq" title="Concentration risk percentage">10</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--StatementGeographicalAxis__stpr--NC__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zylXnLud9Qg9" title="Concentration risk percentage">12</span>% of the Company’s business activity is with customers located in North Carolina for 2023 and 2022, respectively. Approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__srt--StatementGeographicalAxis__stpr--SC__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zqkVD3J6c8R5" title="Concentration risk percentage">10</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--StatementGeographicalAxis__stpr--SC__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zne3JhH8WJ61" title="Concentration risk percentage">9</span>% of the Company’s business activity is with customers located in South Carolina for 2023 and 2022, respectively. There were no other significant regional, industrial or group concentrations during the years ended December 31, 2023 and 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	250200	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	482479	usd
CY2023Q4	spfx	Insured Balances InsuredBalances	250000	usd
CY2022Q4	spfx	Insured Balances InsuredBalances	250000	usd
CY2023Q4	spfx	Balances At Institutions That Do Not Exceed Fdic Limit BalancesAtInstitutionsThatDoNotExceedFdicLimit	45239	usd
CY2022Q4	spfx	Balances At Institutions That Do Not Exceed Fdic Limit BalancesAtInstitutionsThatDoNotExceedFdicLimit	17758	usd
CY2023Q4	spfx	Plus Cash Overdraft PlusCashOverdraft	168543	usd
CY2022Q4	spfx	Plus Cash Overdraft PlusCashOverdraft	0	usd
CY2023Q4	spfx	Outstanding Checks OutstandingChecks	-668743	usd
CY2022Q4	spfx	Outstanding Checks OutstandingChecks	-329026	usd
CY2023Q4	spfx	Cash And Overdraft Amount CashAndOverdraftAmount	45239	usd
CY2022Q4	spfx	Cash And Overdraft Amount CashAndOverdraftAmount	421211	usd
CY2023Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	650237	usd
CY2022Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	603816	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	207400	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1035000	shares
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	93700	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	93700	shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	10000	shares
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	10000	shares
CY2023Q4	spfx	Insurance Premium Finance Contracts Outstanding InsurancePremiumFinanceContractsOutstanding	57769501	usd
CY2022Q4	spfx	Insurance Premium Finance Contracts Outstanding InsurancePremiumFinanceContractsOutstanding	45520349	usd
CY2023Q4	spfx	Insurance Premium Finance Contracts Cancelled InsurancePremiumFinanceContractsCancelled	5832574	usd
CY2022Q4	spfx	Insurance Premium Finance Contracts Cancelled InsurancePremiumFinanceContractsCancelled	6005601	usd
CY2023Q4	spfx	Insurance Premium Finance Contracts Gross InsurancePremiumFinanceContractsGross	63602075	usd
CY2022Q4	spfx	Insurance Premium Finance Contracts Gross InsurancePremiumFinanceContractsGross	51525950	usd
CY2023Q4	spfx	Amounts Due From Agents AmountsDueFromAgents	804131	usd
CY2022Q4	spfx	Amounts Due From Agents AmountsDueFromAgents	645648	usd
CY2023Q4	spfx	Unearned Interest UnearnedInterest	2164914	usd
CY2022Q4	spfx	Unearned Interest UnearnedInterest	1567197	usd
CY2023Q4	spfx	Insurance Premium Finance Contracts Net InsurancePremiumFinanceContractsNet	62241292	usd
CY2022Q4	spfx	Insurance Premium Finance Contracts Net InsurancePremiumFinanceContractsNet	50604401	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1501593	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1129498	usd
CY2023Q4	spfx	Premium Finance Contracts And Related Receivable Net PremiumFinanceContractsAndRelatedReceivableNet	60739699	usd
CY2022Q4	spfx	Premium Finance Contracts And Related Receivable Net PremiumFinanceContractsAndRelatedReceivableNet	49474903	usd
CY2023Q4	spfx	Allowance For Premium Finance Contracts AllowanceForPremiumFinanceContracts	1336157	usd
CY2022Q4	spfx	Allowance For Premium Finance Contracts AllowanceForPremiumFinanceContracts	1000000	usd
CY2023Q4	spfx	Allowance For Amounts Due From Agents AllowanceForAmountsDueFromAgents	165436	usd
CY2022Q4	spfx	Allowance For Amounts Due From Agents AllowanceForAmountsDueFromAgents	129498	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1501593	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1129498	usd
CY2022Q4	us-gaap	Debtor In Possession Financing Interest Rate On Borrowings Outstanding DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding	0.0525	pure
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1129498	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1193757	usd
CY2023	spfx	Current Year Additions To Allowance CurrentYearAdditionsToAllowance	1669000	usd
CY2022	spfx	Current Year Additions To Allowance CurrentYearAdditionsToAllowance	1347475	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1639416	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1513814	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	342511	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	102080	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1501593	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1129498	usd
CY2023	spfx	Current Additions To Allowance CurrentAdditionsToAllowance	1669000	usd
CY2022	spfx	Current Additions To Allowance CurrentAdditionsToAllowance	1347475	usd
CY2023	spfx	Contra Revenues ContraRevenues	718185	usd
CY2022	spfx	Contra Revenues ContraRevenues	613435	usd
CY2023	spfx	Provision For Credit Losses ProvisionForCreditLosses	950815	usd
CY2022	spfx	Provision For Credit Losses ProvisionForCreditLosses	734040	usd
CY2023Q4	spfx	Premium Finance Contracts Outstanding PremiumFinanceContractsOutstanding	57769501	usd
CY2023Q4	spfx	Premium Finance Contracts Cancelled PremiumFinanceContractsCancelled	5832574	usd
CY2023Q4	spfx	Premium Finance Contracts Gross PremiumFinanceContractsGross	63602075	usd
CY2022Q4	spfx	Premium Finance Contracts Outstanding PremiumFinanceContractsOutstanding	45520349	usd
CY2022Q4	spfx	Premium Finance Contracts Cancelled PremiumFinanceContractsCancelled	6005601	usd
CY2022Q4	spfx	Premium Finance Contracts Gross PremiumFinanceContractsGross	51525950	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	386317	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	348399	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	263817	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	244808	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	122500	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103591	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25292	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22283	usd
CY2023Q4	us-gaap	Debtor In Possession Financing Interest Rate On Borrowings Outstanding DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding	0.0525	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	68308	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	45918	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	13879	usd
CY2023Q4	spfx	Lessee Operating Lease Liability Payments Dues LesseeOperatingLeaseLiabilityPaymentsDues	128105	usd
CY2023Q4	spfx	Less Imputed Interest LessImputedInterest	6706	usd
CY2023Q4	spfx	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	121399	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	80840	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	196407	usd
CY2023Q4	spfx	Server Lease ServerLease	38664	usd
CY2022Q4	spfx	Server Lease ServerLease	51920	usd
CY2023Q4	spfx	Total Lease Assets TotalLeaseAssets	119504	usd
CY2022Q4	spfx	Total Lease Assets TotalLeaseAssets	248327	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	50594	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	122554	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30246	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	73853	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	80840	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	196407	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	13166	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	12494	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	27393	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	40559	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	40559	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	53053	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y11M19D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	123127	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	114086	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	27490	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	97978	usd
CY2023Q4	srt	Drafts Payable DraftsPayable	2681359	usd
CY2022Q4	srt	Drafts Payable DraftsPayable	1827884	usd
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable	123924	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	215776	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	92785	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	91852	usd
CY2023Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	31139	usd
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	123924	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	1243021	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	2441523	usd
CY2023	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	496000	usd
CY2022	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	507000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	350212	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	575511	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	771576	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	288400	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.18
CY2023	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.08	pure
CY2023Q4	spfx	Notes Payables NotesPayables	587000	usd
CY2022Q4	spfx	Notes Payables NotesPayables	862000	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	154000	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	156000	usd
CY2023	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	190000	usd
CY2022	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	35000	usd
CY2023	spfx	Repayments Of Other Notes Payable RepaymentsOfOtherNotesPayable	27000	usd
CY2022	spfx	Repayments Of Other Notes Payable RepaymentsOfOtherNotesPayable	181302	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	193962	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	256841	usd
CY2023	spfx	Temporary Differences TemporaryDifferences	-1971	usd
CY2022	spfx	Temporary Differences TemporaryDifferences	-57772	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-11500	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	7121	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	180491	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	206190	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.2100	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	0.0380	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	0.0437	pure
CY2023	spfx	Effective Income Tax Rate Reconciliation Nondeductible Expenses EffectiveIncomeTaxRateReconciliationNondeductibleExpenses	-0.0161	pure
CY2022	spfx	Effective Income Tax Rate Reconciliation Nondeductible Expenses EffectiveIncomeTaxRateReconciliationNondeductibleExpenses	0.0070	pure
CY2023	spfx	Change In Temporary Differences ChangeInTemporaryDifferences	-0.0028	pure
CY2022	spfx	Change In Temporary Differences ChangeInTemporaryDifferences	-0.0571	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0000	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2291	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2036	pure
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	337080	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	253715	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	28336	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	11257	usd
CY2023Q4	spfx	Book To Tax Depreciation BookToTaxDepreciation	25584	usd
CY2022Q4	spfx	Book To Tax Depreciation BookToTaxDepreciation	23192	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	391000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	288164	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	391000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	288164	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	spfx	Designated Shares DesignatedShares	600000	shares
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	10
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	1689050	usd
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	10
CY2023	us-gaap	Dividends Dividends	116200	usd
CY2022	us-gaap	Dividends Dividends	89191	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	29050	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	29050	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2905016	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2905016	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2905016	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2905016	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	207400	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	197400	shares
CY2023	spfx	Sharesbased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.00
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	187400	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.80
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P8Y2M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	20000	shares
CY2022	spfx	Weighted Average Exercise Price Options Issued WeightedAverageExercisePriceOptionsIssued	4.73
CY2022	spfx	Sharebased Compensation Shares Issued Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesIssuedAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P7Y6M
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	207400	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.18
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P7Y1M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1091236	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	0	shares
CY2023	spfx	Weighted Average Exercise Price Options Issued WeightedAverageExercisePriceOptionsIssued	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	207400	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.18
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P6Y1M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	705224	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	197400	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.00
CY2023	spfx	Sharesbased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y1M28D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	704924	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	28200	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	19878	usd
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	975000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.28
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y6M
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2022	spfx	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Issued ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued	60000	shares
CY2022	spfx	Weighted Average Exercise Price Issued WeightedAverageExercisePriceIssued	4.00
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2022	spfx	Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1035000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.09
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y7M6D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	1549400	usd
CY2023	spfx	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Issued ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued	0	shares
CY2023	spfx	Weighted Average Exercise Price Issued WeightedAverageExercisePriceIssued	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2023	spfx	Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1035000	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.09
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y7M6D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	355600	usd
CY2023Q4	spfx	Warrants Exercisable WarrantsExercisable	1035000	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	7.09
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P1Y7M6D
CY2023Q4	spfx	Sharebased Compensation Arrangement By Sharebased Payment Award Otherthan Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOtherthanOptionsExercisableIntrinsicValue1	355600	usd
CY2022Q2	spfx	Warrant Issued For Services WarrantIssuedForServices	10800	usd
CY2021Q2	spfx	Warrant Issued For Services WarrantIssuedForServices	9275	usd
CY2020Q2	spfx	Warrant Issued For Services WarrantIssuedForServices	27200	usd
CY2023	spfx	Stock Warrant Expense StockWarrantExpense	0	usd
CY2022	spfx	Stock Warrant Expense StockWarrantExpense	10800	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	30688	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	50000	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	2088000	usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1925000	usd

Files In Submission

Name	View Source	Status
0001079973-24-000379-index-headers.html	Edgar Link	pending
0001079973-24-000379-index.html	Edgar Link	pending
0001079973-24-000379.txt	Edgar Link	pending
0001079973-24-000379-xbrl.zip	Edgar Link	pending
ex10x12.htm	Edgar Link	pending
ex10x15.htm	Edgar Link	pending
ex10x7.htm	Edgar Link	pending
ex31z1.htm	Edgar Link	pending
ex31z2.htm	Edgar Link	pending
ex32z1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
spfx-20231231.xsd	Edgar Link	pending
spfx-20231231_def.xml	Edgar Link	unprocessable
spfx-20231231_lab.xml	Edgar Link	unprocessable
spfx-20231231_pre.xml	Edgar Link	unprocessable
spfx_10k.htm	Edgar Link	pending
spfx_10k_htm.xml	Edgar Link	completed
spfx-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SPFX
STANDARD PREMIUM FINANCE HOLDINGS, INC. Stock $spfx

2024 Q1 Form 10-K Financial Statement

#000107997324000379 Filed on March 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPFX STANDARD PREMIUM FINANCE HOLDINGS, INC. Stock $spfx

2024 Q1 Form 10-K Financial Statement

#000107997324000379 Filed on March 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPFX
STANDARD PREMIUM FINANCE HOLDINGS, INC. Stock $spfx